Liver Toxicity in Epidemiological Cohorts
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (Supplement) , S49-S55
- https://doi.org/10.1086/381447
Abstract
Hepatotoxicity has been demonstrated to be associated with antiretroviral therapy. Previous studies have included small numbers of patients and, thusKeywords
This publication has 10 references indexed in Scilit:
- Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination TherapyThe Journal of Infectious Diseases, 2002
- Lack of Hepatotoxicity Associated With Nonnucleoside Reverse Transcriptase InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA CohortAIDS, 2002
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAARTJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyAIDS, 2001
- Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infectionAIDS, 2000
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus InfectionJAMA, 2000
- Hepatotoxicity after introduction of highly active antiretroviral therapyAIDS, 1998